Mao Junqing,Li Linjie,Li Minju,et al.Recent advances of diagnosing and treating malignant extracranial germ cell tumors in children[J].Journal of Clinical Pediatric Surgery,,21():1134-1140.[doi:10.3760/cma.j.cn101785-202103017-007]
Recent advances of diagnosing and treating malignant extracranial germ cell tumors in children
- Abstract:
- Germ cell neoplasms are a group of heterogeneous diseases derived from primitive germ cells.Histological types are classified as teratoma,malignant germ cell tumor and mixed germ cell tumor.The major international collaborations for the study of reproductive cell tumors in children are Children’s Oncology Group (COG) in the United States,Canada and Australia and Children’s Cancer and Leukaemia Group (CCLG) in the United Kingdom.This review summarized the latest international research advances in clinical stages,risk groups,chemotherapeutic regimens and managements of refractory and recurrent children with extracranial malignant germ cell tumors.
References:
[1] Dehner LP.Gonadal and extragonadal germ cell neoplasia of childhood[J].Hum Pathol,1983,14(6):493-511.DOI:10.1016/s0046-8177(83)80004-5.
[2] Shaikh F,Murray MJ,Amatruda JF,et al.Paediatric extracranial germ-cell tumours[J].Lancet Oncol,2016,17(4):e149-e162.DOI:10.1016/S1470-2045(15)00545-8.
[3] Poynter JN,Amatruda JF,Ross JA.Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States,1975 to 2006[J].Cancer,2010,116(20):4882-4891.DOI:10.1002/cncr.25454.
[4] Rogers PC,Olson TA,Cullen JW,et al.Treatment of children and adolescents with stage Ⅱ testicular and stages Ⅰ and Ⅱ ovarian malignant germ cell tumors:a pediatric intergroup study-Pediatric Oncology Group 9048 and Children’s Cancer Group 8891[J].J Clin Oncol,2004,22(17):3563-3569.DOI:10.1200/JCO.2004.01.006.
[5] Frazier AL,Hale JP,Rodriguez-Galindo C,et al.Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States[J].J Clin Oncol,2015,33(2):195-201.DOI:10.1200/JCO.2014.58.3369.
[6] Olson TA,Murray MJ,Rodriguez-Galindo C,et al.Pediatric and adolescent extracranial germ cell tumors:the road to collaboration[J].J Clin Oncol,2015,33(27):3018-3028.DOI:10.1200/JCO.2014.60.5337.
[7] Oltmann SC,Garcia NM,Barber R,et al.Pediatric ovarian malignancies:how efficacious are current staging practices?[J].J Pediatr Surg,2010,45(6):1096-1102.DOI:10.1016/j.jpedsurg.2010.02.069.
[8] Frazier AL,Rumcheva P,Olson T,et al.Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors:a report from the Children’s Oncology Group[J].Pediatr Blood Cancer,2008,50(4):746-751.DOI:10.1002/pbc.21304.
[9] G?bel U,Schneider DT,Teske C,et al.Brain metastases in children and adolescents with extracranial germ cell tumor-data of the MAHO/MAKEI-registry[J].Klin Padiatr,2010,222(3):140-144.DOI:10.1055/s-0030-1249661.
[10] Huang J,Tan Y,Zhen Z,et al.Role of post-chemotherapy radiation in the management of children and adolescents with primary advanced malignant mediastinal germ cell tumors[J].PLoS One,2017,12(8):e0183219.DOI:10.1371/journal.pone.0183219.
[11] Ablin AR,Krailo MD,Ramsay NK,et al.Results of treatment of malignant germ cell tumors in 93 children:a report from the Children’s Cancer Study Group[J].J Clin Oncol,1991,9(10):1782-1792.DOI:10.1200/JCO.1991.9.10.1782.
[12] Cushing B,Giller R,Cullen JW,et al.Randomized comparison of combination chemotherapy with etoposide,bleomycin,and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors:a pediatric intergroup study-Pediatric Oncology Group 9049 and Children’s Cancer Group 8882[J].J Clin Oncol,2004,22(13):2691-2700.DOI:10.1200/JCO.2004.08.015.
[13] Malogolowkin MH,Krailo M,Marina N,et al.Pilot study of cisplatin,etoposide,bleomycin,and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors:a report of the Children’s Oncology Group (COG)[J].Pediatr Blood Cancer,2013,60(10):1602-1605.DOI:10.1002/pbc.24601.
[14] Shaikh F,Cullen JW,Olson TA,et al.Reduced and compressed cisplatin-based chemotherapy in children and adolescents with intermediate-risk extracranial malignant germ cell tumors:a report from the children’s oncology group[J].J Clin Oncol,2017,35(11):1203-1210.DOI:10.1200/JCO.2016.67.6544.
[15] Mann JR,Raafat F,Robinson K,et al.The united kingdom children’s cancer study group’s second germ cell tumor study:carboplatin,etoposide,and bleomycin are effective treatment for children with malignant extracranial germ cell tumors,with acceptable toxicity[J].J Clin Oncol,2000,18(22):3809-3818.DOI:10.1200/JCO.2000.18.22.3809.
[16] Depani S,Stoneham S,Krailo M,et al.Results from the UK Children’s Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII)[J].Eur J Cancer,2019,118:49-57.DOI:10.1016/j.ejca.2019.05.001.
[17] Frazier AL,Stoneham S,Rodriguez-Galindo C,et al.Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours:a report of the malignant germ cell international consortium[J].Eur J Cancer,2018,98:30-37.DOI:10.1016/j.ejca.2018.03.004.
[18] Rashdan S,Einhorn LH.Salvage therapy for patients with germ cell tumor[J].J Oncol Pract,2016,12(5):437-443.DOI:10.1200/JOP.2016.011411.
[19] Sr LPJ,Einhorn LH,Williams SD.VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer[J].J Clin Oncol,1986,4(4):528-536.DOI:10.1200/JCO.1986.4.4.528.
[20] Sr LPJ,Gonin R,Nichols CR,et al.Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor[J].J Clin Oncol,1998,16(7):2500-2504.DOI:10.1200/JCO.1998.16.7.2500.
[21] Kondagunta GV,Bacik J,Donadio A,et al.Combination of paclitaxel,ifosfamide,and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors[J].J Clin Oncol,2005,23(27):6549-6555.DOI:10.1200/JCO.2005.19.638.
[22] Perego P,Robert J.Oxaliplatin in the era of personalized medicine:from mechanistic studies to clinical efficacy[J].Cancer Chemother Pharmacol,2016,77(1):5-18.DOI:10.1007/s00280-015-2901-x.
[23] Seidel C,Oechsle K,Lorch A,et al.Efficacy and safety of gemcitabine,oxaliplatin,and paclitaxel in cisplatin-refractory germ cell cancer in routine care-registry data from an outcomes research project of the german testicular cancer study group[J].Urol Oncol,2016,34(4):167.e21-e28.DOI:10.1016/j.urolonc.2015.11.007.
[24] Pashankar F,Frazier AL,Krailo M,et al.Treatment of refractory germ cell tumors in children with paclitaxel,ifosfamide,and carboplatin:a report from the children’s oncology group agct0521 study[J].Pediatr Blood Cancer,2018,65(8):e27111.DOI:10.1002/pbc.27111.
[25] De Pasquale MD,D’Angelo P,Angelo P,et al.Salvage treatment for children with relapsed/refractory germ cell tumors:the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience[J].Pediatr Blood Cancer,2020,67(3):e28125.DOI:10.1002/pbc.28125.
Memo
收稿日期:2021-3-9。
基金项目:浙江省自然科学基金青年项目(LQ20H160027)
通讯作者:王金湖,Email:wjh@zju.edu.cn